Literature DB >> 2969092

Regional infusion of fluoropyrimidines for hepatic metastases of colorectal cancer.

C H Koks1, J R Brouwers, D T Sleijfer.   

Abstract

Recent reports on regional chemotherapy for hepatic metastases of colorectal origin are reviewed. Because of reported side effects and lack of evidence for its superiority over conventional intravenous administration, intra-arterial administration of fluoropyrimidines cannot be advised for routine use, but should be restricted to centres participating in clinical trials on this subject.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969092     DOI: 10.1007/bf01962681

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  25 in total

1.  A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.

Authors:  W D Ensminger; A Rosowsky; V Raso; D C Levin; M Glode; S Come; G Steele; E Frei
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  A retrospective study of the natural history of patients with liver metastases from colorectal cancer.

Authors:  C B Wood; C R Gillis; L H Blumgart
Journal:  Clin Oncol       Date:  1976-09

3.  Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2'-deoxyuridine.

Authors:  D C Hohn; R J Stagg; D C Price; B J Lewis
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

4.  Treatment of colorectal cancer hepatic metastases by hepatic artery chemotherapy.

Authors:  A M Cohen; S D Kaufman; W C Wood
Journal:  Dis Colon Rectum       Date:  1985-06       Impact factor: 4.585

5.  Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy.

Authors:  J G Fortner; J S Silva; E B Cox; R B Golbey; H Gallowitz; B J Maclean
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

Review 6.  Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver.

Authors:  R J Stagg; B J Lewis; M A Friedman; R J Ignoffo; D C Hohn
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

7.  Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.

Authors:  M M Kemeny; H Battifora; D W Blayney; G Cecchi; D A Goldberg; L A Leong; K A Margolin; J J Terz
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

8.  Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.

Authors:  J G Wagner; J W Gyves; P L Stetson; S C Walker-Andrews; I S Wollner; M K Cochran; W D Ensminger
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

9.  Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.

Authors:  D C Hohn; A A Rayner; J S Economou; R J Ignoffo; B J Lewis; R J Stagg
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

10.  Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.

Authors:  K V Shepard; B Levin; R C Karl; J Faintuch; R A DuBrow; M Hagle; R M Cooper; J Beschorner; D Stablein
Journal:  J Clin Oncol       Date:  1985-02       Impact factor: 44.544

View more
  1 in total

Review 1.  Advanced and controlled drug delivery systems in clinical disease management.

Authors:  J R Brouwers
Journal:  Pharm World Sci       Date:  1996-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.